CITADEL ADVISORS LLC: SAIL position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of CITADEL ADVISORS LLC on SAIL, newest first. How the timeline and the estimate are built.
CITADEL ADVISORS LLC held 589,042 SAIL shares at 2026-06-30 per its 13F-HR/A filed 2026-09-02.
the latest 13F is the newest step
- period ended2026-06-3013F/A 589,042 sharesChange vs previous 13F -4,461,948 shares
<0.01% of the 13F portfolio, value $8,623,575.
13F-HR/A 0001104659-26-104387 filed by CITADEL ADVISORS LLC
Accepted , ingested - period ended2026-03-3113F 5,050,990 sharesChange vs previous 13F +3,398,849 shares
0.05% of the 13F portfolio, value $66,875,108.
13F-HR 0001104659-26-062477 filed by CITADEL ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 1,652,141 sharesChange vs previous 13F +1,449,857 shares
0.02% of the 13F portfolio, value $33,422,812.
13F-HR 0001104659-26-016408 filed by CITADEL ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 202,284 sharesChange vs previous 13F -998,515 shares
<0.01% of the 13F portfolio, value $4,466,431.
13F-HR 0001104659-25-112514 filed by CITADEL ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 1,200,799 sharesChange vs previous 13F -2,093,332 shares
0.02% of the 13F portfolio, value $27,450,265.
13F-HR 0001104659-25-078555 filed by CITADEL ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 3,294,131 sharesChange vs previous 13F not available
0.06% of the 13F portfolio, value $61,764,956.
13F-HR 0000950123-25-005687 filed by CITADEL ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).